Q2 2019 Hansa Biopharma AB Earnings Call Transcript
Ladies and gentlemen, welcome to the Hansa Biopharma Q2 report for 2019. Today, I am pleased to present Søren Tulstrup, President and CEO. (Operator Instructions). Søren, please begin.
¸ - ()-&
Thank you, operator. Good afternoon, and good morning in the U.S. Welcome to the Hansa Biopharma conference call on the results for the first 6 months of 2019. Today, we will review the overall progress and highlights for the second quarter as well as the near-term milestones. Our presentation should take about 15 minutes. And after that, we'll take your questions.
My name is Søren Tulstrup, the CEO of Hansa Biopharma. With me today, I have our new CFO, Donato Spota, who recently joined the company. Also, our Head of Investor Relations, Klaus Sindahl, is with us today.
Please turn to Slide 2. Please allow me to draw your attention to our forward-looking statement, which applies to this presentation.
Please turn to Slide 3.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |